Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Huntington disease stories

Nov 2, 2026

FDA sets May 2027 review date for uniQure's Huntington's gene therapy

The FDA will review uniQure's gene therapy for Huntington's disease, with a decision expected in May 2027. The agency has also scheduled an advisory committee meeting.

Nov 2, 2026·2 sources
00
Sep 29, 2026

UniQure's Huntington's gene therapy shows weaker benefit after four years

UniQure reported its gene therapy for Huntington's disease showed diminished benefits at four years compared to three years in a small trial, with shares plunging 48% as the results cast doubt on the treatment's long-term efficacy.

Sep 29, 2026·3 sources
00
Sep 2, 2026

UniQure seeks FDA approval for Huntington's gene therapy after reversal

Dutch biotech UniQure submitted its Huntington's disease gene therapy to the FDA for approval after the agency reversed its earlier position on the experimental treatment, following an unusually turbulent development process.

Sep 2, 2026·3 sources
00
May 4, 2026

Latus Bio Raises $42 Million to Advance Huntington's Disease Gene Therapy Trial

Latus Bio secured $42 million in funding as it prepares to seek FDA approval to begin a clinical trial for its gene therapy targeting Huntington's disease, a progressive neurodegenerative disorder.

May 4, 2026·1 source
00

Top claims

  • ▪The U.S. Food and Drug Administration is considering holding a meeting of outside expert advisors to discuss uniQure's AMT-130 application
  • ▪The U.S. Food and Drug Administration's decision to review AMT-130 ended a standoff during which a senior agency official previously characterized the treatment as a "failed product."
  • ▪The U.S. Food and Drug Administration is reviewing uniQure's AMT-130 under its accelerated approval pathway based on early- to mid-stage trial data from 51 treated patients compared to external controls

Topics

Neurodegenerative diseaseFDA drug approvalClinical trialsGene therapyGenetic diseasesAccelerated approval pathwaysDrug Policy, Pricing & ApprovalDrug Approval and Clinical TrialsClinical Genomics & GeneticsFDA drug approval processNew drug application (NDA) processFintech regulationPharma

Related entities

United StatesNetherlands